Recommended Pages at pharmatimes.com
Why P2P engagement on docs social networks is crucial 4 pharma... via @FarmerFunster http://t.co/E9YxHvI1 #hcsmeu #pharma #hcsm
pharmatimes.com — “Why P2P engagement on docs social networks is crucial 4 pharma... via @FarmerFunster http://t.co/E9YxHvI1 #hcsmeu #pharma #hcsm” View full resource at pharmatimes.com
Most Recently Shared on May 4, 2012 at 10:48 am By:
Len Starnes Pharma, Health Executive, Health Social Media, and Health Marketing
Why P2P engagement on docs social networks is crucial 4 pharma... via @FarmerFunster http://t.co/E9YxHvI1 #hcsmeu #pharma #hcsm
Article > GSK sharpens digital strategy with Infosys, Fabric pact
pharmatimes.com — “Article > GSK sharpens digital strategy with Infosys, Fabric pact” View full resource at pharmatimes.com
Most Recently Shared on March 21, 2012 at 11:25 am By:
Gabor Gyarmati Health Social Media
GSK sharpens digital strategy allowing it to listen and better understand consumers http://t.co/4m8vkq1T #hcsm #hcsmeu RT @H2Ohu
Article > NicOx stock leaps as glaucoma drug heads into Phase III
pharmatimes.com — “Article > NicOx stock leaps as glaucoma drug heads into Phase III” View full resource at pharmatimes.com
Most Recently Shared on March 17, 2012 at 3:00 am By:
Luca M. Sergio Health Social Media and Health Executive
NicOx stock leaps as glaucoma drug heads into Phase III #ophthalmology http://t.co/mRldYyeZ
Article > GPs offer govt "sensible alternative" to Health Bill
pharmatimes.com — “Article > GPs offer govt "sensible alternative" to Health Bill” View full resource at pharmatimes.com
Most Recently Shared on March 6, 2012 at 11:11 am By:
Article GPs offer govt "sensible alternative" to Health Bill: http://t.co/S9ZOjVMJ via @AddThis
Article > AZ starts selling Arimidex direct to patients in USA
pharmatimes.com — “Article > AZ starts selling Arimidex direct to patients in USA” View full resource at pharmatimes.com
Most Recently Shared on February 17, 2012 at 1:32 pm By:
Kurt Proctor Doctor, Pharmacist, and PhD
Via @don_dailyRx AZ goes DTC with breast cancer drug Arimidex to US patients for $30 co-pay premium -- sold by ESI -- http://t.co/4COyofEE
Article > Licensing deals down as pharma tightens belt
pharmatimes.com — “Article > Licensing deals down as pharma tightens belt” View full resource at pharmatimes.com
Most Recently Shared on January 26, 2012 at 1:39 pm By:
On a big M&A day, some #s on last year's deals: M&A up, but licensing down by 16%. Cancer, Roche dominate—PharmaTimes http://t.co/ZHdJjxEa
Article > B-MS signs new research deal with Simcere of China
pharmatimes.com — “Article > B-MS signs new research deal with Simcere of China” View full resource at pharmatimes.com
Most Recently Shared on December 14, 2011 at 1:58 pm By:
BMS expands pact with China's Simcere to include development of a compound for cardiovascular disease. http://t.co/R1dTef9A
Article > UK could do better in cancer, asthma, COPD care: study
pharmatimes.com — “Article > UK could do better in cancer, asthma, COPD care: study” View full resource at pharmatimes.com
Most Recently Shared on November 27, 2011 at 2:24 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
UK could do better in cancer, asthma, COPD care: study http://t.co/7GJfaH8q
Article > Novartis files COPD drug in Japan
pharmatimes.com — “Article > Novartis files COPD drug in Japan” View full resource at pharmatimes.com
Most Recently Shared on November 27, 2011 at 2:23 pm By:
Michael Blaiss, MD Doctor, Allergist, and Physician
Novartis files COPD drug in Japan http://t.co/hxBlR7iD
Article > Lilly puts another US$4 million into Infectious Disease Research Institute
pharmatimes.com — “Article > Lilly puts another US$4 million into Infectious Disease Research Institute” View full resource at pharmatimes.com
Most Recently Shared on November 22, 2011 at 5:42 pm By:
Global Health Health Organization
@LillyPad invests US$4 million in infectious disease research institute http://t.co/cL2t2Luq #TB #globalhealth
Article > Excitement as new class of malaria drug is found
pharmatimes.com — “Article > Excitement as new class of malaria drug is found” View full resource at pharmatimes.com
Most Recently Shared on November 21, 2011 at 7:55 pm By:
Global Health Health Organization
New class of #malaria drug is found by @Novartis Research Foundation & @ScrippsResearch http://t.co/46fSgDRo #globalhealth #R&D
Article > FDA puts back decision on Takeda's new diabetes drugs
pharmatimes.com — “Article > FDA puts back decision on Takeda's new diabetes drugs” View full resource at pharmatimes.com
Most Recently Shared on November 18, 2011 at 2:39 pm By:
FDA puts back decision on Takeda's new diabetes drugs | PharmaTimes http://t.co/4d07QE2n
Medical Devices - Regulatory Affairs Advisors Jobs in Ireland
pharmatimes.com — “Medical Devices - Regulatory Affairs Advisors Jobs in Ireland” View full resource at pharmatimes.com
Most Recently Shared on October 30, 2011 at 4:33 pm By:
Drugs and Devices OW OW Health
Medical Devices - Regulatory Affairs Advisors Jobs in Ireland - Pharma Times: Medical Devices - Regul... http://t.co/xUqHo0eE #MedDevice
Article > Breast cancer drug sales dip, but set for slow growth
pharmatimes.com — “Article > Breast cancer drug sales dip, but set for slow growth” View full resource at pharmatimes.com
Most Recently Shared on October 28, 2011 at 10:45 am By:
Generics like Taxotere, Gemzar will hurt RT @PharmaTimes: Breast cancer drug sales dip, but set for slow growth http://t.co/MPP0xOBX #pharma
Article > Sales up as Lilly prepares for life after Zyprexa
pharmatimes.com — “Article > Sales up as Lilly prepares for life after Zyprexa” View full resource at pharmatimes.com
Most Recently Shared on October 21, 2011 at 11:21 am By:
Sales up as Lilly prepares for life after Zyprexa - Pharma Times http://t.co/bCcvZ3lY
